Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
about
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer TherapyDNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of CancerOne mouse, one patient paradigm: New avatars of personalized cancer therapyRegulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinomaThe future of patient-derived tumor xenografts in cancer treatment.Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabineTargeting lung cancer through inhibition of checkpoint kinases.Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinomaMechanisms of chemoresistance in cancer stem cells.Cancer stem cells and chemoresistance: The smartest survives the raidThe novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair.Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.Cancer subclonal genetic architecture as a key to personalized medicine.The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties.AMPK and Cancer.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancer.Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer CellsOvercoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationSOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells.Wnt-driven intestinal tumourigenesis is suppressed by Chk1 deficiency but enhanced by conditional haploinsufficiency.Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells.
P2860
Q26740207-63FCA02A-0A8E-40A6-951B-1C2FFDE1D86DQ26776513-ADDB17AF-4D6B-4A7E-AB6D-52BA50A73E80Q27023342-7B0FAD53-7ADE-4832-93BF-B84A7D383DC1Q27330365-4BFB28AF-795B-4EC5-B58B-342A8474BBB4Q28534618-8CBE8141-FDC7-43CD-AB6E-55883BDC8A5FQ33361578-8A13065B-B866-42CA-B849-48591D673C3FQ34067873-9B75C2E5-0140-43C7-883B-A156B2966F62Q34154791-4D2035BE-7D4F-44A9-9A20-A76BBAB8841DQ35128547-7DF3B8D9-43A5-44BA-ABBD-0BAAB2564459Q35444029-85496E95-2072-4A53-A775-04CDDFF7F5D5Q36591484-1017B94E-6D65-42C8-AB14-18DAF34DC910Q36730432-0C944F4B-8A4F-4393-BA2B-B6FD4C85DF9CQ36927012-A2BDD883-2622-42DE-B927-688B1749FA62Q37362644-975DF6EE-041E-4C43-8D4F-A273B1FB9B22Q37448116-253CCB93-43EB-4996-A977-F9B860AB4D82Q38287226-51B9C894-77DE-4433-A2BB-DFE8437222F6Q38324456-A02C0A9E-C12C-48A8-8FC4-2C8F97D00B63Q38824383-B038E295-0DFA-4B04-A5E7-7C195D170CB5Q38954172-28CEB34A-B1DF-43C6-A628-82981FD5A60AQ38998413-B699E308-F222-4172-9FDC-A9740577E771Q39031410-704F3FB0-C0BB-4B1A-B614-801F91CA4911Q39034833-2ACFC87A-9481-4289-8864-633FF93BB7D4Q39204274-C80532AC-EEC0-4981-9724-C3C458F144C6Q41470356-50444792-3943-4763-BBA0-7C450ABCE040Q41879186-F533314F-DE2B-4717-9CB2-B45F93AD17C2Q42092920-DD777A47-6B3D-4CE4-8165-FD78B1B1F487Q44513883-BB22F2B6-2A89-418D-A9DC-58E1E34A0B72Q48232893-AF4A9A8C-1CE8-4CB5-858C-652BD3113518
P2860
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
@ast
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
@en
type
label
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
@ast
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
@en
prefLabel
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
@ast
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
@en
P2093
P2860
P356
P1433
P1476
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.
@en
P2093
Diane M Simeone
Jonathan Maybaum
Joshua D Parsels
Leslie A Parsels
Meredith A Morgan
Sonya D Zabludoff
Theodore S Lawrence
Venkatasubbaiah A Venkatesha
P2860
P304
P356
10.1593/NEO.12538
P577
2012-06-01T00:00:00Z